Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71351 - 71375 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	KRT17	3872	downregulated	Silicon Dioxide analog results in decreased expression of KRT17 mRNA	17q21.2	A24194
Silicon dioxide	Approved	KRT19	3880	upregulated	Silicon Dioxide analog results in increased expression of KRT19 mRNA	17q21.2	A24195
Silicon dioxide	Approved	KRT20	54474	downregulated	Silicon Dioxide analog results in decreased expression of KRT20 mRNA	17q21.2	A24195
Silicon dioxide	Approved	KRT222	125113	downregulated	Silicon Dioxide analog results in decreased expression of KRT222 mRNA	17q21.2	A24195
Silicon dioxide	Approved	KRT23	25984	upregulated	Silicon Dioxide results in increased expression of KRT23 mRNA	17q21.2	A24196
Silicon dioxide	Approved	KRT33B	3884	upregulated	Silicon Dioxide results in increased expression of KRT33B mRNA	17q21.2	A24196
Silicon dioxide	Approved	KRT34	3885	upregulated	Silicon Dioxide analog results in increased expression of KRT34 mRNA	17q21.2	A24195
Silicon dioxide	Approved	KRT34	3885	upregulated	Silicon Dioxide results in increased expression of KRT34 mRNA	17q21.2	A24196
Silicon dioxide	Approved	KRT4	3851	downregulated	Silicon Dioxide analog results in decreased expression of KRT4 mRNA	12q13.13	A24195
Silicon dioxide	Approved	KRT4	3851	downregulated	Silicon Dioxide results in decreased expression of KRT4 mRNA	12q13.13	A24196
Silicon dioxide	Approved	KRT75	9119	upregulated	Silicon Dioxide results in increased expression of KRT75 mRNA	12q13.13	A24196
Silicon dioxide	Approved	KRT80	144501	upregulated	Silicon Dioxide analog results in increased expression of KRT80 mRNA	12q13.13	A24195
Silicon dioxide	Approved	KRT86	3892	downregulated	Silicon Dioxide analog results in decreased expression of KRT86 mRNA	12q13	A24195
Silicon dioxide	Approved	KRT9	3857	upregulated	Silicon Dioxide results in increased expression of KRT9 mRNA	17q21.2	A24196
Silicon dioxide	Approved	KRTAP1-5	83895	upregulated	Silicon Dioxide analog results in increased expression of KRTAP1-5 mRNA	17q21.2	A24195
Silicon dioxide	Approved	KRTAP2-3	730755	upregulated	Silicon Dioxide analog results in increased expression of KRTAP2-3 mRNA	17q21.2	A24195
Silicon dioxide	Approved	KRTAP4-1	85285	downregulated	Silicon Dioxide analog results in decreased expression of KRTAP4-1 mRNA	17q21.2	A24195
Silicon dioxide	Approved	KRTAP5-AS1	338651	downregulated	Silicon Dioxide analog results in decreased expression of KRTAP5-AS1 mRNA	11p15.5	A24195
Silicon dioxide	Approved	KSR1	8844	downregulated	Silicon Dioxide analog results in decreased expression of KSR1 mRNA	17q11.2	A24195
Silicon dioxide	Approved	KSR2	283455	downregulated	Silicon Dioxide analog results in decreased expression of KSR2 mRNA	12q24.22-q24.23	A24194
Silicon dioxide	Approved	KYNU	8942	upregulated	Silicon Dioxide results in increased expression of KYNU mRNA	2q22.2	A24197 A24196
Silicon dioxide	Approved	L1CAM	3897	upregulated	Silicon Dioxide analog results in increased expression of L1CAM mRNA	Xq28	A24195
Silicon dioxide	Approved	LAMA2	3908	downregulated	Silicon Dioxide results in decreased expression of LAMA2 mRNA	6q22.33	A24196
Silicon dioxide	Approved	LAMA3	3909	upregulated	Silicon Dioxide analog results in increased expression of LAMA3 mRNA	18q11.2	A24195
Silicon dioxide	Approved	LAMB3	3914	upregulated	Silicon Dioxide analog results in increased expression of LAMB3 mRNA	1q32.2	A24194

Displaying entries 71351 - 71375 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability